Inside Precision Medicine October 17, 2024
Physicians will now be able to order Myriad Genetics’ MyRisk® Hereditary Cancer Test and view the results of the test directly in Flatiron Health’s cloud-based electronic medical record (EMR) platform, OncoEMR. MyRisk is the first hereditary cancer test to be incorporated into Flatiron’s OncoEMR. Myriad is a genetic testing pioneer, while Flatiron has spearheaded the use of AI and real-world evidence to create software that improves and streamlines cancer patients’ experiences.
Myriad’s MyRisk with RiskScore evaluates 48 genes associated with 11 different hereditary cancers. Notably, it was developed for patients of all ancestries. The integration with OncoEMR allows 4,200 providers at over 800 community-based cancer care locations in Flatiron’s network across the U.S. to conveniently order, receive, and review MyRisk...
Today's Sponsors
Today's Sponsor